Citation: | Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification for pathology of organ transplantation (2019 edition): lung transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 383-392. doi: 10.3969/j.issn.1674-7445.2019.04.007 |
[1] |
陈实, 郭晖.移植病理学[M].北京:人民卫生出版社, 2009: 200-218.
|
[2] |
陈实.移植免疫学[M].武汉:湖北科学技术出版社, 1998: 227-229.
|
[3] |
杨树东, 蔡颖, 夏钰弘, 等.移植肺病理学及其进展[J/CD].实用器官移植电子杂志, 2017, 5(6): 454-458. DOI: 10.3969/j.issn.2095-5332.2017.06.013.
YANG SD, CAI Y, XIA YH, et al. Pathology of lung allograft and its progress[J/CD]. Pract J Organ Transplant (Electr Vers), 2017, 5(6): 454-458. DOI: 10.3969/j.issn.2095-5332.2017.06.013.
|
[4] |
HUNT J, STEWART S, CARY N, et al. Evaluation of the International Society for Heart Transplantation (ISHT) grading of pulmonary rejection in 100 consecutive biopsies[J]. Transpl Int, 1992, 5 (Suppl 1):S249-S251.
|
[5] |
RODEN AC, AISNER DL, ALLEN TC, et al. Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: a perspective from members of the Pulmonary Pathology Society[J]. Arch Pathol Lab Med, 2017, 141(3):437-444. DOI: 10.5858/arpa.2016-0459-SA.
|
[6] |
STEWART S, FISHBEIN MC, SNELL GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection[J]. J Heart Lung Transplant, 2007, 26(12):1229-1242. doi: 10.1016/j.healun.2007.10.017
|
[7] |
BERRY GJ, BRUNT EM, CHAMBERLAIN D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation[J]. J Heart Transplant, 1990, 9(6):593-601.
|
[8] |
YOUSEM SA, BERRY GJ, CAGLE PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group[J]. J Heart Lung Transplant, 1996, 15(1 Pt 1):1-15.
|
[9] |
YOUSEM SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients[J]. Am J Surg Pathol, 1993, 17(5):491-496. doi: 10.1097/00000478-199305000-00008
|
[10] |
COOPER JD, BILLINGHAM M, EGAN T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 1993, 12(5):713-716.
|
[11] |
TAKEMOTO SK, ZEEVI A, FENG S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation[J]. Am J Transplant, 2004, 4(7):1033-1041. doi: 10.1111/ajt.2004.4.issue-7
|
[12] |
IONESCU DN, GIRNITA AL, ZEEVI A, et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody[J]. Transpl Immunol, 2005, 15(1):63-68. doi: 10.1016/j.trim.2005.05.001
|
[13] |
SAINT MARTIN GA, REDDY VB, GARRITY ER, et al. Humoral (antibody-mediated) rejection in lung transplantation[J]. J Heart Lung Transplant, 1996, 15(12):1217-1222.
|
[14] |
MAGRO CM, DENG A, POPE-HARMAN A, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis[J]. Transplantation, 2002, 74(9):1273-1280. doi: 10.1097/00007890-200211150-00013
|
[15] |
MAGRO CM, KLINGER DM, ADAMS PW, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related[J]. Am J Transplant, 2003, 3(10):1264-1272. doi: 10.1046/j.1600-6143.2003.00229.x
|
[16] |
LEVINE DJ, GLANVILLE AR, ABOYOUN C, et al. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2016, 35(4):397-406. DOI: 10.1016/j.healun.2016.01.1223.
|
[17] |
DENICOLA MM, WEIGT SS, BELPERIO JA, et al. Pathologic findings in lung allografts with anti-HLA antibodies[J]. J Heart Lung Transplant, 2013, 32(3):326-332. DOI: 10.1016/j.healun.2012.11.018.
|
[18] |
WALLACE WD, LI N, ANDERSEN CB, et al. Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies[J]. J Heart Lung Transplant, 2016, 35(1):40-48. DOI: 10.1016/j.healun.2015.08.021.
|
[19] |
SATO M, WADDELL TK, WAGNETZ U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction[J]. J Heart Lung Transplant, 2011, 30(7):735-742. DOI: 10.1016/j.healun.2011.01.712.
|
[20] |
OFEK E, SATO M, SAITO T, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis[J]. Mod Pathol, 2013, 26(3):350-356. DOI: 10.1038/modpathol.2012.171.
|
[21] |
SATO M, HWANG DM, WADDELL TK, et al. Progression pattern of restrictive allograft syndrome after lung transplantation[J]. J Heart Lung Transplant, 2013, 32(1):23-30. DOI: 10.1016/j.healun.2012.09.026.
|
[22] |
VERLEDEN SE, VANDERMEULEN E, RUTTENS D, et al. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS)[J]. Semin Respir Crit Care Med, 2013, 34(3):352-360. DOI: 10.1055/s-0033-1348463.
|
[23] |
VOS R, VANAUDENAERDE BM, VERLEDEN SE, et al. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection[J]. Transplantation, 2012, 94(2):101-109. DOI: 10.1097/TP.0b013e31824db9da.
|
[24] |
BURGUETE SR, MASELLI DJ, FERNANDEZ JF, et al. Lung transplant infection[J]. Respirology, 2013, 18(1):22-38. DOI: 10.1111/j.1440-1843.2012.02196.x.
|
[25] |
MIYAGAWA-HAYASHINO A, WAIN JC, MARK EJ. Lung transplantation biopsy specimens with bronchiolitis obliterans or bronchiolitis obliterans organizing pneumonia due to aspiration[J]. Arch Pathol Lab Med, 2005, 129(2):223-226. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_e61664d972833c940dfc654b5a140e67
|
[26] |
RICHMOND I, PRITCHARD GE, ASHCROFT T, et al. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers[J]. Thorax, 1993, 48(11):1130-1134. doi: 10.1136/thx.48.11.1130
|
[27] |
ZAKI KS, ARYAN Z, MEHTA AC, et al. Recurrence of lymphangioleiomyomatosis: nine years after a bilateral lung transplantation[J]. World J Transplant, 2016, 6(1):249-254. DOI: 10.5500/wjt.v6.i1.249.
|
[28] |
MEYER KC, RAGHU G, VERLEDEN GM, et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome[J]. Eur Respir J, 2014, 44(6):1479-1503. DOI: 10.1183/09031936.00107514.
|
[29] |
BENNETT D, FOSSI A, REFINI RM, et al. Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature[J]. Tumori, 2016, 102(6):574-581. DOI: 10.5301/tj.5000557.
|
[30] |
李雯, 冯靖.诊断性介入肺脏病学快速现场评价临床实施指南[J].天津医药, 2017, 45(4):441-448. DOI: 10.11958/20170320.
LI W, FENG J. Clinical implementation guidelines of rapid field evaluation in diagnostic interventional pulmonary disease[J]. Tianjin Med J, 2017, 45(4):441-448. DOI: 10.11958/20170320.
|